Abstract: A high-temperature (HT) SPICE model of the silicon carbide (SiC) nMOS and pMOS along with the transient characteristics is presented in this article. This work extends the BSIM4SiC model, ...
It happens each year when the weather turns cold: The coats, hats, sweaters and blankets come out. The lights come on earlier. And the arguments over how high or low to set the thermostat begin. But ...
A US Navy Global Autonomous Reconnaissance Craft (GARC) maneuvers in the Atlantic Ocean during UNITAS 2025 on Sept. 23, 2025. US Navy photo ARLINGTON, Va. — A new office consolidating the development ...
Forbes contributors publish independent expert analyses and insights. Ian writes on fossil energies, climate, and transition to renewables. The recent Department of Energy Report, A Critical Review of ...
Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...
Abstract: Hydrogen fuel cell electric vehicles have gained significant attention in the future mobility industry due to their fast refueling capabilities and long driving range. Hydrogen sensors play ...
Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. Baraka is perhaps the most interesting personality in a crowded Democratic primary to ...
I am a proud, unapologetic progressive with a proven track record of action to protect our most vulnerable residents, create better education for our children, and forge pathways to affordable rent ...
We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Michael is a former senior editor of investing and trading products for ...
Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results